A new trading day began on Friday, with Plus Therapeutics Inc (NASDAQ: PSTV) stock price up 7.14% from the previous day of trading, before settling in for the closing price of $0.68. PSTV’s price has ranged from $0.16 to $2.31 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 46.51% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 90.26%. With a float of $99.00 million, this company’s outstanding shares have now reached $99.26 million.
Plus Therapeutics Inc (PSTV) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Plus Therapeutics Inc is 0.26%, while institutional ownership is 3.19%. The most recent insider transaction that took place on Aug 22 ’25, was worth 53,779. In this transaction Director of this company bought 110,000 shares at a rate of $0.49, taking the stock ownership to the 139,327 shares. Before that another transaction happened on May 15 ’25, when Company’s Director proposed sale 36,666 for $0.55, making the entire transaction worth $20,276.
Plus Therapeutics Inc (PSTV) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.37 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 90.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 62.44% during the next five years compared to 46.51% growth over the previous five years of trading.
Plus Therapeutics Inc (NASDAQ: PSTV) Trading Performance Indicators
Here are Plus Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.23, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach -0.11 in one year’s time.
Technical Analysis of Plus Therapeutics Inc (PSTV)
Let’s dig in a bit further. During the last 5-days, its volume was 55.3 million. That was better than the volume of 20.93 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 64.38%.
During the past 100 days, Plus Therapeutics Inc’s (PSTV) raw stochastic average was set at 77.08%, which indicates a significant increase from 71.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0704 in the past 14 days, which was higher than the 0.0690 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5458, while its 200-day Moving Average is $0.7254. However, in the short run, Plus Therapeutics Inc’s stock first resistance to watch stands at $0.7617. Second resistance stands at $0.7921. The third major resistance level sits at $0.8345. If the price goes on to break the first support level at $0.6889, it is likely to go to the next support level at $0.6465. The third support level lies at $0.6161 if the price breaches the second support level.
Plus Therapeutics Inc (NASDAQ: PSTV) Key Stats
With a market capitalization of 72.58 million, the company has a total of 99,265K Shares Outstanding. Currently, annual sales are 5,820 K while annual income is -12,980 K. The company’s previous quarter sales were 1,390 K while its latest quarter income was 5,150 K.
